Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Medicine|June 30, 2022
Re-irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic indexSalvador Gutierrez Torres, Federico Maldonado Magos, Jenny G Turcott, et al.
International Journal of Radiation Oncology, Biology, Physics|April 29, 2021
Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II StudyFederico Maldonado, Ana Gonzalez-Ling, Luis F Oñate-Ocaña, et al.
Thoracic Cancer|February 20, 2020
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation statusOscar Arrieta, Laura-Alejandra Ramírez-Tirado, Enrique Caballé-Perez, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II studyOscar Arrieta, Feliciano Barrón, Federico Maldonado, et al.
Frontiers in Oncology|February 18, 2025
Case report: Chest radiotherapy-induced vertebral fractures in lung cancer patients: a case series and literature reviewOscar Arrieta, Francisco Lozano-Ruiz, Alberto Guijosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 18, 2011
Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot studyMartín Granados García, María Fátima Chilaca Rosas, Arturo Javier Lavín Lozano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2026
Long‑term outcomes of prophylactic cranial irradiation in high‑risk metastatic NSCLC: Final PRoT‑BM analysisLuis Cabrera-Miranda, Federico Maldonado, Eduardo Rios-Garcia, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical TrialOscar Arrieta, Norma Hernández-Pedro, Federico Maldonado, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2021
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 studyMónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, et al.
Frontiers in Oncology|December 19, 2025
Correction: Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancerOscar Arrieta, Laura Margarita Bolaño-Guerra, Enrique Caballé-Pérez, et al.
Pageof 3